Connecting Healthcare Professionals to Scientiﬁc Information
UCBCOMPASS® provides scientiﬁc education and
medical information on UCB medicines used to treat
certain immune-mediated inﬂammatory conditions.
UCB continues to proactively monitor the COVID-19 situation. To learn more about UCB's preparedness, click here.
BIMZELX® (bimekizumab-bkzx) is now FDA approved for the treatment of adults with plaque psoriasis. See the phase 3 clinical trial data in Publications.
The Women's Health Fellowship Program application is now closed. Learn More
Listen to Podcasts
Gain insights as scientists, medical experts, and patients discuss advances and unmet needs in inﬂammatory autoimmune conditions.
Review the latest UCB research, including original articles, from peer-reviewed sources.
Opportunities for Investigators
Submit a study concept, request access to patient-level data from UCB trials, or become a UCB clinical trial investigator.